Shanghai Fosun Pharmaceutical (Gr.../ CNE100001M79 /
18/06/2024 00:00:00 | Chg. -0.12 | Volume | Bid10:08:05 | Ask10:08:05 | High | Low |
---|---|---|---|---|---|---|
13.04HKD | -0.91% | 3.37 mill. Turnover: 37.19 mill. |
13.04Bid Size: - | 13.06Ask Size: - | 13.26 | 12.98 |
GlobeNewswire
22/10/2021
Genetron Health and Fosun Pharma Announce Exclusive Partnership to Commercialize Seq-MRD® in China
GlobeNewswire
12/10/2021
Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® ora...
GlobeNewswire
13/01/2021
Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wa...
GlobeNewswire
07/01/2021
Dräger Extends Ventilation Solutions Into U.S. Long-Term Care Facilities Through Breas Medical Distr...
GlobeNewswire
29/09/2020
Polyphor Announces Closing of Fosun Pharma Licensing Agreement for balixafortide in China and Receip...